Tag

Mifepristone

All articles tagged with #mifepristone

Three Southern States Sue Supreme Court to Strike Down Abortion Pill Shield Laws
politics10 days ago

Three Southern States Sue Supreme Court to Strike Down Abortion Pill Shield Laws

On September 30, 2026, Louisiana, Alabama, and Arkansas filed a Supreme Court lawsuit challenging 'shield laws' in New York, California, and Massachusetts. These laws protect out-of-state providers who mail abortion pills to patients in states with bans. Simultaneously, the three states sued 30 providers for false advertising and illegal distribution. The move escalates a post-Dobbs legal conflict over interstate medical access, with blue-state governors vowing to defend reproductive rights while red-state officials cite public safety and sovereignty.

FDA Nominee Heidi Overton Dodges Direct Answers on Vaccine Safety and Abortion Pill
politics14 days ago

FDA Nominee Heidi Overton Dodges Direct Answers on Vaccine Safety and Abortion Pill

Heidi Overton, President Trump’s nominee for FDA commissioner, faced a grueling confirmation hearing on September 24, 2026, where she refused to directly answer whether the president was wrong about the safety of the MMR vaccine. While she affirmed that the vaccine is 'safe and effective,' she avoided confirming if she would push back against presidential directives that contradict scientific consensus. Senators also pressed her on the abortion pill mifepristone and flavored vapes, with Overton citing ongoing safety reviews and agency guidance to deflect specific questions about regulatory changes.

politics16 days ago

FDA Nominee Overton Defends MMR Safety, Navigates Abortion Pill and Vaccine Scrutiny

Dr. Heidi Overton, the White House nominee for FDA commissioner, told senators that the measles, mumps, and rubella (MMR) vaccine is 'safe and effective,' directly contradicting President Trump’s recent claim that the shot is 'lethal.' During her confirmation hearing, Overton faced intense scrutiny from both parties regarding her stance on the abortion pill mifepristone and her support for the administration’s vaccine policy. While she affirmed the safety of current vaccines, she deflected questions about potential regulatory changes to mifepristone, citing an ongoing safety review. The hearing highlighted deep divisions within the Senate, with some Republicans questioning her loyalty to the president and others worried about her anti-abortion views, while Democrats criticized her background in conservative policy circles.

politics16 days ago

Overton’s FDA Confirmation Hinges on Mifepristone and Vaccine Disputes

Heidi Overton, President Trump’s nominee for FDA commissioner, faced a contentious Senate confirmation hearing on September 24, 2026. Her path to confirmation is complicated by conflicting stances on mifepristone and vaccines, drawing criticism from both Democrats and moderate Republicans. While she affirmed the safety of the measles vaccine, contradicting the President, her ambiguous stance on abortion pills and lack of agency leadership experience have raised doubts among key committee members.

Legal battles intensify over telehealth abortion-pill access
politics1 month ago

Legal battles intensify over telehealth abortion-pill access

States and conservative groups are suing to overturn FDA rules that allow mifepristone via telehealth, arguing such access clashes with bans in many states. Federal cases involving Louisiana, Texas and others are pressing the FDA as courts weigh whether prescribing rules are too restrictive, with a status update deadline of Oct. 7 in some matters. Even if limits tighten, abortion pills could still be accessible through alternatives like misoprostol, sparking debates about state control vs. federal oversight and the future of telehealth for this medication.

politics4 months ago

Pro-Life Coalition Fractures With Trump Over Abortion Pill Access

After the Supreme Court preserved access to telemedicine abortions, anti-abortion groups intensified pressure on the Trump administration to act on abortion pills and funding for Planned Parenthood, pressing meetings with the FDA and DOJ and signaling that failure could hurt GOP turnout in the midterms; they want swift use of powers to curb access, including potential moves like the Comstock Act to ban mail-order abortions and defund Planned Parenthood, though some insiders caution the White House ultimately holds the leverage.

Abortion bans linked to slower, less evidence-based miscarriage care
health4 months ago

Abortion bans linked to slower, less evidence-based miscarriage care

An OHSU study in JAMA finds state abortion bans correlate with reduced evidence-based miscarriage management, shifting care toward expectant management and more misoprostol-only regimens, delaying treatment and potentially harming health and fertility, with greater impact on Medicaid/low-income patients amid legal uncertainty surrounding mifepristone.

Dissent Signals Fresh Front in Mifepristone Fight as Telehealth Access Survives
politics4 months ago

Dissent Signals Fresh Front in Mifepristone Fight as Telehealth Access Survives

The Supreme Court allowed the continued mailing and telehealth dispensing of mifepristone while the case plays out, but conservative Justices Thomas and Alito dissented, warning that enforcing the 1873 Comstock Act could threaten broader abortion access and hinting at a renewed federal abortion ban push. The decision preserves a critical lifeline for medication abortion in the near term, though advocates warn the threat to access remains tied to ongoing regulatory reviews, potential political maneuvering ahead of the midterms, and the Dobbs framework that eliminated a nationwide abortion right. Medication abortions already account for a large share of U.S. procedures, and while misoprostol-alone options exist, experts note they are less convenient and carry more side effects. This remains a high-stakes, politically charged battleground for abortion access.

health-care4 months ago

Acting FDA chief seeks pro-life reassurance after Planned Parenthood ties emerge

Acting FDA Commissioner Kyle Diamantas has been telling anti‑abortion leaders he personally opposes abortion while facing questions about past work as outside counsel for a Planned Parenthood Florida clinic (2014–2017) and his later removal from that case for conscience reasons; some filings still list him, prompting skepticism from conservatives. The FDA has pledged a science‑based review of the abortion pill’s REMS and to provide updates, while Diamantas did not respond to questions about the case; the White House defended him amid ongoing debates over mifepristone policy and the agency’s leadership.

Court Keeps Mail-Order Abortion Pill Accessible as Legal Fight Continues
politics4 months ago

Court Keeps Mail-Order Abortion Pill Accessible as Legal Fight Continues

The Supreme Court paused a lower-court ruling that would have required in-person pickup of the abortion pill mifepristone, allowing patients to continue receiving it by mail and via telehealth while Louisiana’s challenge to FDA rules proceeds, a decision issued with dissent from Justices Thomas and Alito. The ruling preserves current access for now but leaves the broader legal battle over medication abortion rules unresolved as the case moves through the courts and across states with bans.